Recombinant Human PNGaseF Protein，His

PNGase F, or Peptide-N-Glycosidase F, is an enzyme that plays a crucial role in the deglycosylation of glycoproteins, specifically by hydrolyzing the asparagine-linked glycan residues. This enzyme has garnered significant attention in the fields of biotechnology and biomedicine due to its ability to remove oligosaccharides from glycoproteins, thereby facilitating studies on protein structure and function. The research surrounding recombinant PNGase F focuses on optimizing its expression in various host systems, including bacteria, yeast, and mammalian cells, to produce sufficient quantities for industrial and research applications. The ability to produce PNGase F recombinantly enhances its availability, as it can be tailored for specific experimental needs, such as studying glycoprotein interactions, structures, and immunogenic properties. Additionally, PNGase F research is critical for developing therapeutic glycoproteins, as glycosylation patterns significantly influence protein stability, efficacy, and immune response. As glycosylation is a pivotal modification affecting the pharmacokinetics and pharmacodynamics of biologics, understanding the enzymatic action of PNGase F can aid in the design of more effective glycoprotein-based therapies. Hence, ongoing research aims to elucidate the mechanism of action, improve enzyme efficiency, and explore novel applications of PNGase F in glycoprotein analysis and therapeutic advances. The integration of recombinant DNA technology and protein engineering is expected to further enhance the utility of PNGase F in various scientific and industrial fields, driving forward the understanding of glycoprotein biology.